investorscraft@gmail.com

Investor's Craft

S&P 500 Health CareS&P 500 EnergyS&P 500 Information Tech.S&P 500 Communic. ServicesS&P 500 Consumer Discret.S&P 500 Consumer StaplesS&P 500 IndustrialsS&P 500 Materials
IntroductionThe concept of valuationRevenue and revenue growthVariable costsFixed costsProduction assets

Intrinsic value of DaVita Inc. (DVA)

Previous Close$85.68
Intrinsic Value$101.34
Upside potential  +18%
Previous Close
$85.68
Intrinsic Value
$101.34
Potential        
+18%

VALUATION INPUT DATA (original, your and others' valuations)

ParameterOrig.Your
Date of valuation (DoV)  
Intrinsic value (IV) at DoV, $/sh  
IV at current val. algorithm, $/sh101.34 101.34

The original valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-03-31.

Registered users can save their valuation input data

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

NOTE: The bar chart shows historic and forecasted yearly revenue growth rates. Its purpose is to help you in determining what initial revenue rate you want to base your stock valuation on. Please make sure that you are confident in the value you select - for most stocks it is by far the most important parameter in valuation.

Company description

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2019, it provided dialysis and administrative services in the United States through a network of 2,753 outpatient dialysis centers serving approximately 206,900 patients; and operated 259 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 28,700 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2021(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %0.6NaN
Revenue, $11619NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m9822NaN
Operating income, $m1797NaN
EBITDA, $m2478NaN
Interest expense (income), $mNaN
Earnings before tax, $m1285NaN
Tax expense, $m307NaN
Net income, $m978NaN

BALANCE SHEET

Cash and short-term investments, $m577NaN
Total assets, $m17871NaN
Adjusted assets (=assets-cash), $m17294NaN
Average production assets, $m13500NaN
Working capital, $m769NaN
Total debt, $m11975NaN
Total liabilities, $m17115NaN
Total equity, $m756NaN
Debt-to-equity ratio15.840NaN
Adjusted equity ratio0.043NaN

CASH FLOW

Net income, $m978NaN
Depreciation, amort., depletion, $m681NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m1934NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-580NaN
Free cash flow, $m2514NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m769
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount